Chris Bulman Inc Viatris Inc Transaction History
Chris Bulman Inc
- $147 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,091Shares Held
935MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA141MShares$1.83 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.2 Billion0.02% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$814 Million4.18% of portfolio
-
State Street Corp Boston, MA62.1MShares$807 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$739 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.8B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...